ACHR three-lens brief
Evidence-based stock research on ACHR. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 10.3pp over 30 days. · Currently unprofitable on a trailing basis — no P/E multiple available.
- Outperforming SPY by 10.3pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $10.94 — 71% above current (9 analysts).
- Negative free cash flow last quarterly (-$458.84M).
- Debt-to-equity of 5.9 — balance-sheet-heavy.
ACHR closed at $6.39 (+0.00%) as of 2026-05-13. Market cap: $4.85B. Positives: outperforming SPY by 10.3pp over 30 days.; analyst mean target $10.94 — 71% above current (9 analysts).. Concerns: currently unprofitable on a trailing basis — no P/E multiple available.; negative free cash flow last quarterly (-$458.84M).. Last quarter: Revenue $1.60M, net income -$217.70M, free cash flow -$458.84M.
Why three lenses on ACHR, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACHRacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACHR" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACHR brief"></iframe>